(Q41835248)
Statements
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer (English)
Yvette Drew
Jonathan Ledermann
Geoff Hall
Daniel Rea
Ros Glasspool
Martin Highley
Gordon Jayson
Julieann Sludden
James Murray
Sarah Halford
Gary Acton
Zoe Backholer
Raffaella Mangano
1 reference